Advertisement

 

 

Dynamics ofmutation and prognostic relevance in patients with primary myelodysplastic syndrome.

Dynamics ofmutation and prognostic relevance in patients with primary myelodysplastic syndrome.
Author Information (click to view)

Lin ME, Hou HA, Tsai CH, Wu SJ, Kuo YY, Tseng MH, Liu MC, Liu CW, Chou WC, Chen CY, Tang JL, Yao M, Li CC, Huang SY, Ko BS, Hsu SC, Lin CT, Tien HF,


Lin ME, Hou HA, Tsai CH, Wu SJ, Kuo YY, Tseng MH, Liu MC, Liu CW, Chou WC, Chen CY, Tang JL, Yao M, Li CC, Huang SY, Ko BS, Hsu SC, Lin CT, Tien HF, (click to view)

Lin ME, Hou HA, Tsai CH, Wu SJ, Kuo YY, Tseng MH, Liu MC, Liu CW, Chou WC, Chen CY, Tang JL, Yao M, Li CC, Huang SY, Ko BS, Hsu SC, Lin CT, Tien HF,

Advertisement

Clinical epigenetics 2018 04 0210() 42 doi 10.1186/s13148-018-0476-1

Abstract
Background
gene mutation has been associated with poor prognosis in acute myeloid leukemia, but its clinical implications in myelodysplastic syndrome (MDS) and dynamic changes during disease progression remain controversial.

Results
In this study,mutation was identified in 7.9% of 469 de novo MDS patients.-mutated patients had higher platelet counts at diagnosis, and patients with ring sideroblasts had the highest incidence ofmutations, whereas those with multilineage dysplasia had the lowest incidence. Thirty-one (83.8%) of 37-mutated patients had additional molecular abnormalities at diagnosis, andmutation was highly associated with mutations ofand. Patients withmutations had a higher risk of leukemia transformation and shorter overall survival. Further,mutation was an independent poor prognostic factor irrespective of age, IPSS-R, and genetic alterations. The sequential study demonstrated that the originalmutations were retained during follow-ups unless allogeneic hematopoietic stem cell transplantation was performed, whilemutation was rarely acquired during disease progression.

Conclusions
mutation predicts unfavorable outcomes in MDS and was stable during disease evolutions. It may thus be a potential biomarker to predict prognosis and monitor the treatment response.

Submit a Comment

Your email address will not be published. Required fields are marked *

seventeen − sixteen =

[ HIDE/SHOW ]